Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional doses of PCV10 and PCV13 in Kenyan infants
NCT03489018Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Mar 2019
- Primary completion
- Sep 2022
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 10-valent pneumococcal conjugate vaccine, Prevnar 13 in pneumococcal infection, sponsored by London School of Hygiene & Tropical Medicine. Started Mar 2019; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinePrevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT03489018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03489018.